This inventor holds 35 USPTO granted patents and 15 published patent applications, plus 6 CIPO patents and 11 EPO patents, primarily in Tetracycline Compounds. Top assignees: Tetraphase Pharmaceuticals, Inc., Miikana Therapeutics, Inc., Takeda San Diego, Inc.. Active years: 1998-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- La Jolla, CA (US) (1999 - 2001)
- San Diego, CA (US) (1998 - 2017)
- Lexington, MA (US) (2014 - 2021)
Company Filing History:
12 out of 18 
6 out of 6 
5 out of 53 
Years Active: 1998-2021
Areas of Expertise:
Title: Innovator Spotlight: Xiao-Yi Xiao
Introduction: Xiao-Yi Xiao, a prolific inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 35 patents. His innovative work in developing tetracycline compounds has garnered recognition in the industry.
Latest Patents: Xiao-Yi Xiao's latest patents showcase his expertise in creating novel tetracycline compounds, as outlined in the structural formula (I) and their pharmaceutically acceptable salts. These compounds, along with their therapeutic applications, represent cutting-edge advancements in pharmaceutical science.
Career Highlights: Throughout his career, Xiao-Yi Xiao has held key positions at renowned companies such as Tetraphase Pharmaceuticals, Inc. and Miikana Therapeutics, Inc. His dedication to research and development has led to the successful patenting of numerous inventions that have the potential to revolutionize the healthcare industry.
Collaborations: Xiao-Yi Xiao has collaborated closely with esteemed colleagues such as Roger B Clark and Louis Plamondon, further enhancing the impact of his innovative projects. Their combined expertise has resulted in the successful implementation of groundbreaking ideas and the attainment of patents that reflect their commitment to excellence.
Conclusion: In conclusion, Xiao-Yi Xiao's groundbreaking work in the field of pharmaceuticals, particularly in the development of tetracycline compounds, underscores his status as a key innovator in the industry. With a remarkable track record of 35 patents and a reputation for collaborative success, Xiao-Yi Xiao continues to drive innovation forward, shaping the future of healthcare with his pioneering inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile